In fact, the originally proposed correlation between 11q23 genetic aberration and upregulated NG2/CSPG4 expression were subsequently further corroborated by computational and flow cytometric analyses performed on 1,461 infants with B-ALL. The gene discussed is CSPG4; the disease is acute lymphoblastic leukemia.